All In Biotech

Drug Trial Radar · NCT06194799

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

A 52-Week, Open-Label Extension Study of ACP-204 in Adults With Alzheimer's Disease Psychosis

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

752

Planned (sponsor's estimate)

Start

Apr 23, 2024

Primary completion

Apr 2029

Study completion May 2029

Sponsor

Lead sponsor
ACADIA Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Jan 8, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 55 years, up to 95 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.

Conditions

  • Alzheimer's Disease Psychosis

Interventions

  • ACP-204Drug

    ACP-204 30 mg given once daily, as capsule OR ACP-204 60 mg given once daily, as capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-emergent adverse eventsTime frame: 52 Weeks

Locations

78 sites in 12 countries. Site status is shown where the registry gives one.

  • Clinical Endpoints LLC

    Scottsdale, Arizona

  • ATP Clinical Research

    Costa Mesa, California

  • Neuro-Pain Medical Center

    Fresno, California

  • National Institute Of Clinical Research

    Garden Grove, California

  • Humanity Clinical Research, Corp

    Aventura, Florida

  • First Excellent Research

    Doral, Florida

  • New Life Medical Research Center

    Hialeah, Florida

  • Reliable Clinical Research LLC

    Hialeah, Florida

  • Homestead Associates in Research Inc.

    Miami, Florida

  • Premier Clinical Research Institute Inc

    Miami, Florida

  • Advanced Clinical Research

    Miami, Florida

  • Verus Clinical Research

    Miami, Florida

  • Quantum Clinical Trials

    Miami, Florida

  • Future Care Solution, LLC

    Miami, Florida

  • MediClear Medical & Research Center, Inc.

    Miami, Florida

  • ABBA Medical Research LLC

    Miami, Florida

  • New Med Research

    Miami Gardens, Florida

  • Floridian Neuroscience Institute

    Miami Lakes, Florida

  • Abington Neurological Associates

    Abington, Pennsylvania

  • Horizon Clinical Research Group

    Cypress, Texas

  • Uni Texas Health Science Center

    Houston, Texas

  • Clinical Trial Network LLC

    Houston, Texas

  • Kaleidoscope Clinical Research

    Houston, Texas

  • Hospital Universitario de Brasilia

    Brasília, Brazil

  • CECPAR Centro de Estudos Clinicos do Parana

    Curitiba, Brazil

  • TrialTech Tecnologia com Pesquisas em Medicamentos

    Curitiba, Brazil

  • Inst de Neurologia de Curitiba Hospital Ecoville

    Curitiba, Brazil

  • Instituto Mederi de Pesquisa e Saude

    Passo Fundo, Brazil

  • Ruschel Medicina e Pesquisa Clínica

    Rio de Janeiro, Brazil

  • Facili - Centro Integrado de Psiquiatria

    São Bernardo do Campo, Brazil

  • BR Trials-Ensaios Clinicos e Consultoria

    São Paulo, Brazil

  • Hospital Moinhos de Vento

    Porto Alegre, Rio Grande do Sul, Brazil

  • ET Dr. Ivo Natsov-AIPSMC in Psychiatry

    Cherven Bryag, Bulgaria

  • DCC Higia

    Pazardzhik, Bulgaria

  • Medical center Medconsult Pleven OOD

    Pleven, Bulgaria

  • Mental Health Centre-Prof. N Shipkovenski EOOD

    Sofia, Bulgaria

  • DCC St. Vrach and St. St. Kuzma and Damian OOD

    Sofia, Bulgaria

  • UMHAT Alexandrovska EAD

    Sofia, Bulgaria

  • Psicomed Estudios Medicos

    Antofagasta, Chile

  • Biomedica Research Group

    Santiago, Chile

Showing 40 of 78 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.